Elevation of cystatin C in susceptible neurons in Alzheimer's disease - Wikidata - awgldk - TriplyDB

Elevation of cystatin C in susceptible neurons in Alzheimer's disease

Elevation of cystatin C in susceptible neurons in Alzheimer's disease

http://www.wikidata.org/entity/Q28350831

about

Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models Hydrogen peroxide induces lysosomal protease alterations in PC12 cells Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease.Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection.Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines.Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study The effects of cystatin C and alkaline phosphatase changes on cognitive function 12-months after bariatric surgery.Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive study.Molecular diversity of astrocytes with implications for neurological disorders.Biochemistry and clinical role of human cystatin C.Protective mechanisms by cystatin C in neurodegenerative diseases.Salivary (SD-type) cystatins: over one billion years in the making--but to what purpose?Biomarkers of renal function and cognitive impairment in patients with diabetes Cystatin C in Alzheimer's disease.Cystatin C Shifts APP Processing from Amyloid-β Production towards Non-Amyloidgenic Pathway in Brain Endothelial Cells.Molecular pathology and pathogenesis of inclusion-body myositis.Expression, purification, and characterization of human cystatin C monomers and oligomers.Cathepsin B degrades amyloid-β in mice expressing wild-type human amyloid precursor protein.Cystatin C as a marker of cognitive function in elders: findings from the health ABC study Serum cystatin C and the risk of Alzheimer disease in elderly men Complexes of amyloid-beta and cystatin C in the human central nervous system.Autophagic/lysosomal dysfunction in Alzheimer's disease.Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis.Cystatin C in aging and in Alzheimer's disease.Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies.Cystatin C has a dual role in post-traumatic brain injury recovery.Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles.Demonstration of multiple novel glycoforms of the stem cell survival factor CCg.Identification of up-regulated genes by array analysis in scrapie-infected mouse brains.Meta-analysis of the cystatin C(CST3) gene G73A polymorphism and susceptibility to Alzheimer's disease.Involvement of dopaminergic neuronal cystatin C in neuronal injury-induced microglial activation and neurotoxicity.Characterization of progenitor-cell-specific genes identified by subtractive suppression hybridization.Cerebral gene expression profiles in sporadic Creutzfeldt-Jakob disease.Amyloid fibril formation by human stefin B: influence of pH and TFE on fibril growth and morphology

P2860

Q24678722-448F1097-C157-40F7-B7EB-85103EA876C8 Q28289057-D4994E4C-3385-4556-9D6A-0C157ECDBD1D Q28307028-AC6C90BD-5D6F-46D9-B3AB-755B986F973F Q28579181-4907583A-ED83-445B-B526-1D65638F119E Q30490690-1AEC5B1C-A139-4181-88FC-1244871BAEA7 Q33204250-BC14B2E2-ECD6-4DCB-AC19-697B6D3C178A Q33547453-E286D956-DD4F-4CDB-81AC-5AAC60E0DA94 Q33782286-0AC6F2E8-B46B-4262-9275-3FADA8BA4CAB Q34258691-7E81D003-370E-4CF2-B55B-05FAC4907A6C Q34361219-E842FFE2-DD49-465B-8755-3ADAA9A90143 Q34375615-918F99DC-D27F-428D-B5CA-39C3D63201AC Q34377103-3E1FAB91-5045-4A44-9EDD-8FFB55290ECC Q34572391-5741E095-DC55-4619-801A-1B6FC3327EF2 Q35033473-1CE021B0-B423-43ED-B349-49473FF0CF72 Q35123472-D85C7BE6-7A98-442C-B341-46BB225784EA Q36078684-A1EFD0F8-26B3-4146-80B9-575A982C6C94 Q36105690-EC8C278B-9F5A-4C4A-AA15-E468D99342E9 Q36231849-3A0E4807-D94F-493D-820E-66AB153112AB Q36385028-74BAC73F-99FB-4235-BA59-CAFE871A992F Q36407861-68F85F13-6238-4A5F-A573-30BD6F04D64B Q36976287-B77D68C3-13A0-42F9-BD1E-E0D4D19CCCDE Q37179085-2760CB9F-111D-44B4-8C28-190F8CFD8A9D Q37474236-3A730AB1-054B-47FE-AAAC-4CA40115275A Q37690932-0E69B21D-9BCF-408F-90BE-1B9CC60896DE Q38643847-CE8591C3-CF90-4FE3-9004-8FFDC09FC0D4 Q38873507-27D04961-F9C8-49A5-BEC6-E1C0809FDEDC Q39340736-BCBF306A-8AFC-40B6-960D-733D40DF0D23 Q39356602-19AFAD71-A476-45B1-AC62-00D874E15AFD Q44465698-C50C688B-FDC2-431E-ACBB-03B60EF1407F Q44936990-4A2E3B70-7E27-4484-8498-E88374C7A99C Q45109402-BE600F65-BB0A-4DF9-A56C-D47FF2995BA8 Q47997840-302AD675-BA8D-49AE-89EB-91D8E0DBF1DE Q50245762-F5F230DB-B6B5-4518-8007-4AA949437B70 Q52057734-145B6217-CE66-4E2A-BBAB-315FE2895AAB Q53664270-686EBE28-F3B7-41D8-9696-5F64ABB200AD Q58179795-CB191C68-B473-4A07-AD55-08D091082824

P2860

Elevation of cystatin C in susceptible neurons in Alzheimer's disease

http://www.wikidata.org/entity/Q28350831

description

2001 nî lūn-bûn

@nan

2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

name

Elevation of cystatin C in susceptible neurons in Alzheimer's disease

@ast

Elevation of cystatin C in susceptible neurons in Alzheimer's disease

@en

Elevation of cystatin C in susceptible neurons in Alzheimer's disease

@nl

type

label

Elevation of cystatin C in susceptible neurons in Alzheimer's disease

@ast

Elevation of cystatin C in susceptible neurons in Alzheimer's disease

@en

Elevation of cystatin C in susceptible neurons in Alzheimer's disease

@nl

prefLabel

Elevation of cystatin C in susceptible neurons in Alzheimer's disease

@ast

Elevation of cystatin C in susceptible neurons in Alzheimer's disease

@en

Elevation of cystatin C in susceptible neurons in Alzheimer's disease

@nl

P1433

Q28350831-B19E6776-F5DE-4700-8AED-6C096D969474

P1476

Q28350831-32323A3D-A5EE-4AC4-AA84-7199A32D3904

P2093

Q28350831-0012B9B3-5F7C-419C-8660-A01763FA3340

Q28350831-27EC83FB-3C6A-4FBE-B2AA-F776EC3DC727

Q28350831-3D7B117B-9A70-4525-8842-8CBE717FCD6D

Q28350831-95BC751A-3598-4FF9-B978-102CFECFEA1A

Q28350831-977749F7-51A4-4845-907C-3CDE4359CFB4

P2860

Q28350831-015097AE-8F9B-4BE4-81B3-AF7759EBDC44

Q28350831-1B58ECC1-B4A6-4308-9B1C-7785AFAE71CA

Q28350831-22601226-7A73-40CA-A318-057003B006AA

Q28350831-274CF63A-DAB9-4FBE-A31B-30AE88D67465

Q28350831-2E29B95F-2DFF-4B3C-A86F-EB4E7F39D2A5

Q28350831-35CCC553-C997-4DA0-960D-3E5C136177D5

Q28350831-3613E9C8-09D1-45F5-9E11-64CD0374B352

Q28350831-4F5E1CA1-B981-4601-A642-9EA48C79612E

Q28350831-511D36DE-E38E-4DBE-B4C4-125B4256123B

Q28350831-54021B0D-BDB4-4EA9-9FF2-26172BECA7E9

P304

Q28350831-F1660A58-3660-4C38-98B7-86AF5FA32025

P31

Q28350831-93A68A25-C974-4FD0-86C5-A79DD29AAFC6

P3181

Q28350831-4CF87840-1EFB-40BE-A8E8-997AD40CE96D

P356

Q28350831-BCF13DAA-0206-4DFD-B1D7-77A9A996D886

P407

Q28350831-8B877DA6-1CD9-4936-802A-0026D4E53109

P433

Q28350831-536342DD-3053-4715-8F64-EC4D3E3D1918

P478

Q28350831-BDE3D7D2-3B6F-438A-B899-666ADD4B99CB

P577

Q28350831-6F687BF5-83D8-4585-A1BE-6A80FEE44B53

P698

Q28350831-5E50F088-A38E-4607-84F6-7AC5ED99173B

P921

Q28350831-F6769C61-EACD-4884-B692-48DC295F8B87

P932

Q28350831-076EAA1D-91B3-4067-94FC-7F7BE0BC40DD

P3181

P356

S0002-9440(10)61781-6

P1433

The American Journal of Pathology

P1476

Elevation of cystatin C in susceptible neurons in Alzheimer's disease

@en

P2093

A Deng

http://www.w3.org/2001/XMLSchema#string

G W Rebeck

http://www.w3.org/2001/XMLSchema#string

J H Growdon

http://www.w3.org/2001/XMLSchema#string

M C Irizarry

http://www.w3.org/2001/XMLSchema#string

R M Nitsch

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids

Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis

Neuropathological stageing of Alzheimer-related changes

FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor

Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia

The cDNA structure and expression analysis of the genes for the cysteine proteinase inhibitor cystatin C and for beta 2-microglobulin in rat brain

Up-regulation of cystatin C by microglia in the rat facial nucleus following axotomy

Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients.

P304

1061-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4047181

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S0002-9440(10)61781-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

159

http://www.w3.org/2001/XMLSchema#string

P577

2001-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11549598

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

1850464

http://www.w3.org/2001/XMLSchema#string